Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GlaxoSmithKline Pharmaceuticals

PUBLIC STATUS
1K-5K EMPLOYEES
500660 STOCK SYMBOL
2 INVESTMENTS
$22.76 SHARE PRICE (As of Wednesday Closing)
Description

GlaxoSmithKline Pharmaceuticals is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
  • Mumbai
  • India
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GlaxoSmithKline Pharmaceuticals’s full profile, request a free trial.

GlaxoSmithKline Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$16.36 - $24.35 $3.86B $22.77 $0.73 11.5K 169M

GlaxoSmithKline Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 3,319,598 2,972,013 5,411,952 6,946,167
Revenue 458,892 446,922 445,384 433,601
EBITDA 163,649 94,883 81,510 69,424
Net Income 123,945 63,634 54,400 50,213
Total Assets 499,106 563,190 606,333 463,191
Total Debt 6,112 84 152 246
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GlaxoSmithKline Pharmaceuticals Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 16-Jul-2015 00000 00000 00 00000 Biotechnology
Silarus Therapeutics 22-Sep-2014 Early Stage VC 0000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

GlaxoSmithKline Pharmaceuticals Board Members (2)

Name Representing Role Since Contact
Info
0. 00000000 Self Board Member 000 0000
00000 000000000 Self Independent and Non-Executive Director 000 0000